| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |